The US Food and Drug Administration (FDA) has announced the approval of Sanofi and Regeneron’s interleukin (IL)-4 and IL-13 ...

The US FDA placed a full clinical hold on two diabetes trials for Biomea’s menin inhibitor after reports of liver toxicity.

The FDA has approved the first treatment for schizophrenia that targets cholinergic receptors rather than dopamine receptors.

UNICEF has reached an agreement with mpox vaccine manufacturer Bavarian Nordic to supply one million doses of the shot for ...

Phare Bio has received up to $27m from the Advanced Research Projects Agency for Health (ARPA-H) to advance its drug ...

The collaboration aims to utilise Tempus’ real-world data and biological modelling to enhance the development of Takeda’s ...

Opioid use disorder (OUD) is a chronic neurological disorder characterised by the compulsive, repeated use of opioids, ...

The FDA has approved AstraZeneca's Tagrisso (osimertinib) to treat adults with unresectable stage III EGFR-mutated NSCLC.

Safety processes and regulations apply to custom-made medicines, which differ from traditional pharmacies. Now, however, ...

Direct-to-patient communication is emerging as a powerful solution to the challenges of non-adherence to medication. By ...

Biocon has entered a partnership with Tabuk for the commercialisation of glucagon-like peptide-1 (GLP-1) products in the ...

West Pharmaceutical Services is a winner in the Safety category in the 2024 Pharmaceutical Technology Excellence Awards.